Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Monlunabant

A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome

Inversago Pharma · Phase 1 · Completed · Enrollment 37

NCT05282446

ArmPopulationDoseWeeksEstimandWeight change
INV-202Metabolic Syndromen/rn/rn/rn/r
PlaceboMetabolic Syndromen/rn/rn/rn/r